Joseph Stringer

Stock Analyst at Needham

(0)
# 4266
Out of 5,298 analysts
318
Total ratings
26.05%
Success rate
-12.94%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
PHAT Phathom Pharmaceutic...
Reiterates: Buy
28 28
5.01 458.88% 49 Apr 2, 2025
PCVX Vaxcyte
Maintains: Buy
140 90
30.48 195.28% 16 Apr 1, 2025
ALNY Alnylam Pharmaceutic...
Reiterates: Buy
320 320
262.05 22.11% 20 Mar 21, 2025
STOK Stoke Therapeutics
Reiterates: Buy
22 22
6.3 249.21% 21 Mar 18, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
64 66
49.78 32.58% 22 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
28.09 113.6% 16 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 15
0.87 1624.14% 17 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
35 35
17.78 96.85% 9 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
1.82 779.12% 18 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 10
1.32 657.58% 17 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
5.96 218.79% 16 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
28.5 110.53% 18 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 4 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 5 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 60
22.53 166.31% 19 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
16.11 129.67% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
8.77 105.25% 2 Aug 24, 2021